Navigation Links
Vertos Medical Inc. Presents Clinical Data of its MILD™ Procedure at the 5th Annual Innovative Techniques in Spine Surgery Conference in Los Cabos, Mexico
Date:7/16/2008

Vertos Medical Inc, a privately held medical device manufacturer focusing on minimally invasive treatment of lumbar spinal stenosis (LSS), announced presentation of its clinical results of its proprietary Minimally Invasive Lumbar Decompression, MILD™, procedure. The MILD procedure, is a simple, percutaneous, fluoroscopically guided treatment for central canal Lumbar Spinal Stenosis,(LSS). MILD can be performed under local anesthesia and substantially reduces the tissue damage and tissue removal associated with other minimally invasive or open surgeries. LSS is diagnosed in 1.5 million Americans each year. Vertos has obtained FDA clearance for sale of the MILD devices in the USA.

San Jose CA (PRWEB) July 16, 2008 -- Vertos Medical Inc, a privately held medical device manufacturer focusing on minimally invasive treatment of lumbar spinal stenosis (LSS), announced presentation of its clinical results of its proprietary Minimally Invasive Lumbar Decompression, MILD™, procedure. The MILD procedure, is a simple, percutaneous, fluoroscopically guided treatment for central canal Lumbar Spinal Stenosis,(LSS). MILD can be performed under local anesthesia and substantially reduces the tissue damage and tissue removal associated with other minimally invasive or open surgeries. LSS is diagnosed in 1.5 million Americans each year. Vertos has obtained FDA clearance for sale of the MILD devices in the USA.

Clinical results on 32 patients with moderate to severe LSS have shown that all patients were discharged either the same day or the day following the MILD™ procedure. These patients were treated at 11 medical centers of excellence. No complications or adverse events were reported.

Clinical results included a 90% decrease in pain as measured by the Visual Analog Scale (VAS), as well as improved mobility, represented by a decrease in the Oswestry Disability Index (ODI) of 84%. All patients reported had discontinued the use of narcotics or pain medication at 6 weeks following the MILD procedure.

These results were presented at the recently held Spine Technology Education Group's 5th Annual Innovative Techniques in Spine Surgery Conference in Los Cabos by Jonathan Hyde MD, a leading spine surgeon. Dr Hyde practices at Mount Sinai Medical Center in Miami Beach, Florida.

"The clinical results presented in Los Cabos are very encouraging and mirror the results the patients I treated in my practice in Miami. The MILD™ procedure certainly offers a minimally invasive alternative to open surgery with short recovery and rehabilitation times" said Jonathan Hyde MD. Richard Johnson MD, Vertos President and CEO added "LSS affects 1.5 million Americans each year. The MILD™ procedure will offer many of these patients a minimally invasive alternative to invasive open surgery, with shorter procedure, hospitalization and rehab times. We are very pleased and encouraged by the clinical results Dr. Hyde presented"

For further information, please contact Herbert Mertens via email at hmertens(at)vertosmed.com or via telephone at (619)602-0061.

###


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. North Carolinas Center For Advanced Medicine & Clinical Research Celebrates Opening of New LKN Medical Spa and Rejuvenation Center
2. Medical And Nursing Scrubs Retailer Blue Sky Scrubs Unveils New Website
3. Alta Bates Medical Group (ABMG) Teams With Illumisys, LLC to Promote Quality of Care to Patients and Increase Adoption and Use of Health Information Technologies.
4. China Sky One Medical, Inc. Signs Distribution Agreement with Harbin Baolong Pharmaceutical Company
5. Electronic Medical Records Are No Longer Limited to Physicians with Deep Pockets
6. Broadlane's Live Group Buy Awards High-Field Open MRI Contract to Hitachi Medical Systems America Inc.
7. The Five Biggest Marketing Mistakes Made By Medical Offices and Small Businesses
8. Medical Devices Get Most Funding in Slow Stretch for VC: Mid-Year Results from Healthcare Corporate Finance News
9. VNUS Medical Technologies to Report Second-Quarter 2008 Results and Webcast Teleconference on July 29
10. Surgeons Use USGI Medicals EndoSurgical Operating System to Complete Live Incisionless Appendectomy at Leading NOTES Conference
11. American Hospital Management Company Appoints Gregory Ciottone, MD as Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... 24, 2016 , ... Those who have experienced traumatic events may suffer from ... avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid this ... coping following a traumatic event. , Trauma sufferers tend to feel a range of ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are ... for this recognition are considered among the top 2 percent of lawyers practicing within ... of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: